Medicinal mushroom Ganoderma iucidum (Leyss: Fr) karst. Triggers immunomodulatory effects and reduces nitric oxide synthesis in mice

Journal of Medicinal Food

Volumn 13, Issue 1, 2010, Pages 142-148

  Rubel, Rosália ^a   Dalla Santa, Herta S ^a   Bonatto, Sandro J R ^a   Bello, Sérgio ^a   Fernandes, Luiz Cláudio ^a   Di Bernardi, Raffaelo ^a   Gern, Juliana ^a   Santos, Cid Aimbiré M ^a   Soccol, Carlos Ricardo ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Cytokines; Edible mushroom; Immunomodulation; Reishi; Tumor necrosis factor

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; HYDROGEN PEROXIDE; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN; NITRIC OXIDE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; EDIBLE MUSHROOM; EX VIVO STUDY; FUNGAL SCLEROTIUM; FUNGUS CULTURE; GANODERMA LUCIDUM; IMMUNOMODULATION; IMMUNOSTIMULATION; IN VIVO STUDY; LYMPHOCYTE SUBPOPULATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SPLEEN LYMPHOCYTE;

ANIMALS; ANTIGENS, CD3; ANTIGENS, CD8; CYTOKINES; DIETARY SUPPLEMENTS; GANODERMA; IMMUNOLOGIC FACTORS; INTERFERON-GAMMA; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; MICE; MYCELIUM; NITRIC OXIDE; SEEDS; SPLEEN; T-LYMPHOCYTE SUBSETS; TRITICUM; TUMOR NECROSIS FACTOR-ALPHA;

BASIDIOMYCOTA; GANODERMA; GANODERMA LUCIDUM; MUS; TRITICUM AESTIVUM;

EID: 76649117752     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2008.0307     Document Type: Article

References (39)

1. Lull C, Wichers HJ, Savelkoul HFJ: Antiinflammatory and immunomodulating properties of fungal metabolites. Mediators Inflamm 2005;2005(2):63-80.
2. Zaidman BZ, Yassin M, Mahajna J, Wasser SP: Medicinal mushroom modulators of molecular targets as cancer therapeutics. Appl Microbiol Biotechnol 2005;67:453-468.
3. Borchers AT, Keen CL, Gershwin E: Mushrooms, tumors, and immunity: an update. Exp Biol Med 2004;229:393-406.
4. Jong SC, Birmingham JM: Medicinal benefits of the mushroom Ganoderma. Adv Appl Microbiol 1992;37:101-134.
5. Wasser SP, Weis AL: Therapeutic effects of substances occurring in higher basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol 1999;19:65-96.
6. Wang SY, Hsu ML, Hsu HC, Tzeng CH, Lee SS, Shiao MS, Ho CK: The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int J Cancer 1997;70:699-705.
7. Song YS, Kim SH, Sa JH, Jin C, Lim CJ, Park EH: Antiangiogenic and inhibitory activity on inducible nitric oxide production of the mushroom Ganoderma lucidum. J Ethnopharmacol 2004;90:17-20.
8. Woo CWH, Man RYK, Siow YL, Choy PC, Wan EWY, Lau CS, Karmin O: Ganoderma lucidum inhibits inducible nitric oxide synthase expression in macrophages. Mol Cell Biochem 2005; 275:165-171.
9. Kidd PM: The use of mushroom glucans and proteoglycans in cancer treatment. Altern Med Rev 2000;5:4-27.
10. Sheena N, Ajith TA, Janardhanan KK: Prevention of nephrotoxicity induced by the anticancer drug cisplatin, using Ganoderma lucidum, a medical mushroom in South India. Curr Sci 2003;85:478-482.
11. Tang YJ, Zhong JJ: Fed-batch fermentation of Ganoderma lucidum for hyperproduction of polysaccharide and ganodermic acid. Enzyme Microb Tech 2002;31:20-28.
12. Official Methods of Analysis of AOAC International, 17th ed. Association of Official Analytical Chemists (AOAC), Gaithersburg, MD, 2000.
13. Wagner H, Bladt S, Zgainski EM: Plant Drug Analysis. Springer Verlag, Berlin, 1984.
14. Matos FJA: Introdução à Fitoquímica Experimental. Universidade Federal do Ceará, Fortaleza, Brazil, 1988.
15. Coligan JE, Kruisbeck AM, Margulies DH, Shevach EM, Strober W, eds.: Current Protocols in Immunology. John Wiley & Sons, New York, 1992.
16. Stuehr PJ, Marletta MA: Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 1985;82:7738-7742.
17. Madhavi N, Das VN: Effects of n-3 and n-6 fatty acids on survival of vineristine sensitive and resistant human cervical carcinoma cells, in vitro. Cancer Lett 1994;84:31-41.
18. Pick E, Mizel M: Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J Immunol 1981;46:211-226.
19. Bonatto JRS, Folador A, Aikawa J, Yamazaki RK, Pizatto N, Oliveira HHP, Vecchi R, Curi R, Calder PC, Fernandes LC: Lifelong exposure to dietary fish oil alters macrophage responses in Walker 256 tumor-bearing rats. Cell Immunol 2004;231: 56-62.
20. Pizato N, Bonatto S, Piconcelli M, de Souza LM, Sassaki GL, Naviwaiko K, Nunes EA, Curi R, Calder PC, Fernandes LC: Fish oil alters T-lymphocyte proliferation and macrophage responses in Walker 256 tumor-bearing rats. Nutrition 2006;22:425-432.
21. Cheung HY, Ng CW, Hood DJ: Identification and quantification of base and nucleoside markers in extracts of Ganoderma lucidum, Ganoderma japonicum and Ganoderma capsules by micellar electrokinetic chromatography. J Chromatography A 2001; 911:119-126.
22. Soccol CR, Vandenberghe LPS: Overview of applied solid-state fermentation in Brazil. Biochem Eng J 2003;13:205-218.
23. Kim YS, Eo SK, Oh KW, Lee CK, Han SS: Antiherpectic activities of acid protein bound polysaccharide isolated from Ganoderma lucidum alone and in combinations with interferons. J Ethnopharmacol 2000;72:451-458.
24. O'Shea JJ, Ma A, Lipsky P: Citokines and autoimmunity. Nat Rev Immunol 2002;2:37-45.
25. Akira S: Roles of STAT3 defined by tissue-specific gene targeting. Oncogene 2000;19:2607-2611.
26. Gao Y, Zhou S, Wen J, Huang M, Xu A: Mechanism of the antiulcerogenic effect of Ganoderma lucidum polysaccharides on indomethacin-induced lesions in the rat. Life Sci 2002;72:731-745.
27. Zhao SP, Zeng LH: Elevated plasma levels of tumor necrosis factor in chronic heart failure with cachexia. Int J Cardiol 1997; 58:257-261.
28. Sharma R, Anker SD: Cytokines, apoptosis and cachexia: the potential for TNF antagonism. Int J Cardiol 2002;85:161-171.
29. Tolosa L, Morlá M, Iglesias A, Busquets X, Lladó J, Olmos G: IFN-g prevents TNF-a-induced apoptosis in C2C12 myotubes through down-regulation of TNF-R2 and increased NF-k B activity. Cell Signal 2005;17:1333-1342.
30. Gadina M, Hilton D, Johnston JA, Morinobu A, Lighvani A, Zhou YJ, Visconti R, O'Shea JJ: Signaling by type I and II cytokine receptors: ten years after. Curr Opin Immunol 2001;13: 363-373.
31. Feldmann M, Brennan FM, Maini RN: Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996;14:397-440.
32. van der Hem LG, van der Vliet JA, Bocken CFM, Kino K, Hoitsma AJ, Tax WJM: Ling zhi-8: studies of a new immunomodulating agent. Transplantation 1995;60:438-443.
33. Rubel R, Dalla Santa HS, Fernandes LC, Lima Filho JHC, Figueiredo BC, Di Bernardi R, Moreno NA, Leifa F, Soccol CR: High immunomodulatory and preventive effects against sarcoma 180 in mice fed with Ling Zhi or Reishi mushroom Ganoderma lucidum (W. Curt.: Fr.) P. Karst. (Aphyllophoromycetideae) mycelium. Int J Med Mushroom 2008;10:37-48.
34. Napoli C, Ignarro LJ: Nitric oxide and atherosclerosis. Nitric Oxide 2001;5:88-97.
35. Chesrown SE, Monnier J, Visner G, Nick HS: Regulation of inducible nitric oxide synthase mRNA levels by LPS, IFNgamma, TGF-beta, and IL-10 in murine macrophage cell lines and rat peritoneal macrophages. Biochem Biophys Res Commun 1994;200:126-134.
36. Khatri JJ, Johnson C, Magid R, Lessner SM, Laude KM, Dikalov SI, Harrison DG, Sung HJ, Rong Y, Galis ZS: Vascular oxidant stress enhances progression and angiogenesis of experimental atheroma. Circulation 2004;109:520-525.
37. Liu F, Ooi VEC, Chang ST: Free radical scavenging activities of mushroom polysaccharide extracts. Life Sci 1997;60:763-771.
38. Yang Q, Huang W, Jozwik C, Lin Y, Glasman M, Caohuy H, Srivastava M, Esposito D, Gillette W, Hartley J, Pollard HB: Cardiac glycosides inhibit TNF-a=NF-kB signaling by blocking recruitment of TNF receptor-associated death domain to the TNF receptor. Proc Natl Acad Sci U S A 2005;102:9631-9636.
39. Newman RA, Yang P, Pawlus AD, Block KI: Cardiac glycosides as novel cancer therapeutic agents. Mol Interv 2008;8: 36-49.